Accuracy of yellow fever case definition of epidemiologic surveillance, São Paulo, 2018
DOI:
https://doi.org/10.11606/s1518-8787.2023057005001Keywords:
Yellow Fever, Accuracy, Case Definition, Epidemiologic SurveillanceAbstract
OBJECTIVE: To evaluate the accuracy of yellow fever (YF) suspected case definitions from the Brazilian Ministry of Health (BMH) and World Health Organization (WHO), as well as propose and evaluate new definitions of suspected cases, considering confirmed and discarded cases. METHODS: The retrospective study was conducted at the Instituto de Infectologia Emílio Ribas (IIER), using the Epidemiologic Surveillance Form of YF cases. From the confirmed and discarded cases of YF, a logistic regression model was developed. The independent variables were used in a proposed definition of a suspected case of YF and its accuracy was evaluated. RESULTS: In total, 113 YF suspect cases were reported, with 78 confirmed (69.0%). The definitions by BMH and WHO presented low sensitivity, 59% and 53.8%, and reduced accuracy, 53.1% and 47.8%, respectively. Predictive factors for YF were thrombocytopenia, leukopenia, and elevation of transaminases greater than twice normal. The definition including individual with acute onset of fever, followed by elevation of ALT or AST greater than twice the reference value AND leukopenia OR thrombocytopenia presented high sensitivity (88.3%), specificity (62.9%), and the best accuracy (80.4%), as proposed in the model. CONCLUSION: The YF suspected case definitions of the BMH and the WHO have low sensitivity. The inclusion of nonspecific laboratory tests increases the accuracy of YF definition.
References
Monath TP, Vasconcelos PF. Yellow fever. J Clin Virol. 2015 Mar;64:160-73. https://doi.org/10.1016/j.jcv.2014.08.030
Banluta C. Yellow fever. Geneva: World Health Organization; (date unkown [cited 2022 May 2]). Available from: https://www.who.int/health-topics/yellow-fever#tab=tab_1/
Secretaria de Estado da Saúde (SP). Coordenadoria de Controle de Doenças. Centro de Vigilância Epidemiológica. Nota Técnica sobre Febre Amarela no estado de São Paulo 2017. [cited 2020 Aug 15]. Available from: http://docs.bvsalud.org/biblioref/2020/05/1095889/famarela17_nota_tecnica.pdf
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Centro de Operações de Emergências em Saúde Pública sobre Febre Amarela. Informe – Nº 43/207. Monitoramento dos casos e óbitos de febre amarela no Brasil. Brasília, DF: Ministério da Saúde; 2017 [cited 2020 May 2]. Available from: https://sbim.org.br/images/files/ms-febreamarela-170531.pdf
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Informe - Nº 21. Monitoramento do Período Sazonal de Fabre Amarela - Brasil - 2017/2018. Brasília, DF:
Ministério da Saúde; 2018 [cited 2020 May 2]. Available from: https://sbim.org.br/images/files/informe-fa-21-11abr18-c.pdf
Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Coordenacao-Geral de Desenvolvimento da Epidemiologia em Servicos. Guia de vigilancia em saude: volume único. 3a ed. Brasilia, DF: Ministerio da Saude; 2019.
Mascheretti M, Tengan CH, Sato HK, Suzuki A, Souza RP, Maeda M, et al. Yellow fever: reemerging in the state of Sao Paulo, Brazil, 2009. Rev Saude Publica. 2013 Oct;47(5):881-9. https://doi.org/10.1590/S0034-8910.2013047004341
World Health Organization. Yellow fever: case definitions for public health surveillance, 2015. Geneva: World Health Organization; (date unkown [cited 2022 May 2]). Available from: http://www.who.int/csr/disease/yellowfev/case-definition/en/
Barrett AD, Teuwen DE. Yellow fever vaccine: how does it work and why do rare cases of serious adverse events take place? Curr Opin Immunol. 2009 Jun;21(3):308-13. https://doi.org/10.1016/j.coi.2009.05.018
Fitzner J, Qasmieh S, Mounts AW, Alexander B, Besselaar T, Briand S, et al. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018 Feb;96(2):122-8. https://doi.org/10.2471/BLT.17.194514
Teutsch SM, Churchill RE, editors. Principles and practice of public health surveillance. New York: Oxford University Press; 2000.
Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep. 1997 May;46 (RR-10):1-55.
Ribeiro AF, Cavalin RF, Suleiman JMAH, Costa JA, Vasconcelos MJ, Málaque CMS, et al. Yellow fever: factors associated with death in a hospital of reference in infectious diseases, São Paulo, Brazil, 2018. Am J Trop Med Hyg. 2019 Jul;101(1):180-8. https://doi.org/10.4269/ajtmh.18-0882
Kallas EG, D’Elia Zanella LG, Moreira CH, Buccheri R, Diniz GB, Castiñeiras AC, et al. Predictors of mortality in patients with yellow fever: an observational cohort study. Lancet Infect Dis. 2019 Jul;19(7):750-8. https://doi.org/10.1016/S1473-3099(19)30125-2
Escosteguy CC, Pereira AG, Marques MR, Lima TR, Galliez RM, Medronho RA. Yellow fever: profile of cases and factors associated with death in a hospital in the State of Rio de Janeiro, 2017-2018. Rev Saúde Pública. 2019 Oct;53:89. https://doi.org/10.11606/s1518-8787.2019053001434
Casadio LV, Salles AP, Malta FM, Leite GF, Ho YL, Gomes-Gouvêa MS, et al. Lipase and factor V (but not viral load) are prognostic factors for the evolution of severe yellow fever cases. Mem Inst Oswaldo Cruz. 2019;114:e190033. https://doi.org/10.1590/0074-02760190033
Braga JU, Bressan C, Dalvi AP, Calvet GA, Daumas RP, Rodrigues N, et al. Accuracy of Zika virus disease case definition during simultaneous Dengue and Chikungunya epidemics. PLoS One. 2017 Jun;12(6):e0179725. https://doi.org/10.1371/journal.pone.0179725
Xavier AR, Freitas GS, Santos CF, Januzzi WA, Lacerda GS, Carvalho ER, et al. Yellow fever: laboratorial diagnosis and clinical manifestations. J Bras Patol Med Lab. 2018;54(5):296–305. https://doi.org/10.5935/1676-2444.20180050
Published
Issue
Section
License
Copyright (c) 2023 Ana Freitas Ribeiro, Roberta Figueiredo Cavalin, Aparecida Mei Mingrone Klimas, Ricardo Manfredo, Luciana Marques Sansão Borges
This work is licensed under a Creative Commons Attribution 4.0 International License.
